Correlation Between Viridian Therapeutics and Accsys Technologies

Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Accsys Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Accsys Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viridian Therapeutics and Accsys Technologies PLC, you can compare the effects of market volatilities on Viridian Therapeutics and Accsys Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Accsys Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Accsys Technologies.

Diversification Opportunities for Viridian Therapeutics and Accsys Technologies

-0.42

Correlation Coefficient

Viridian Therapeutics  Accsys Technologies

Very good diversification

The 3 months correlation between Viridian and Accsys is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Accsys Technologies PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Accsys Technologies PLC and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Accsys Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Accsys Technologies PLC has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Accsys Technologies go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Accsys Technologies

Assuming the 90 days trading horizon Viridian Therapeutics is expected to generate 1.96 times more return on investment than Accsys Technologies. However, Viridian Therapeutics is 1.96 times more volatile than Accsys Technologies PLC. It trades about 0.14 of its potential returns per unit of risk. Accsys Technologies PLC is currently generating about -0.03 per unit of risk. If you would invest  1,486  in Viridian Therapeutics on September 2, 2024 and sell it today you would earn a total of  696.00  from holding Viridian Therapeutics or generate 46.84% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Viridian Therapeutics  vs.  Accsys Technologies PLC

Viridian Therapeutics

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Viridian Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Viridian Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Accsys Technologies PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Accsys Technologies PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Accsys Technologies is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Viridian Therapeutics and Accsys Technologies

The main advantage of trading using opposite Viridian Therapeutics and Accsys Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Accsys Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accsys Technologies will offset losses from the drop in Accsys Technologies' long position.

The idea behind Viridian Therapeutics and Accsys Technologies PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.